HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Combination therapy with verteporfin and anti-VEGF agents in neovascular age-related macular degeneration: where do we stand?

AuthorsPeter K Kaiser
JournalThe British journal of ophthalmology (Br J Ophthalmol) Vol. 94 Issue 2 Pg. 143-5 (Feb 2010) ISSN: 1468-2079 [Electronic] England
PMID20139287 (Publication Type: Editorial, Research Support, Non-U.S. Gov't, Comment)
Chemical References
  • Angiogenesis Inhibitors
  • Photosensitizing Agents
  • Porphyrins
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Verteporfin
Topics
  • Angiogenesis Inhibitors (therapeutic use)
  • Choroidal Neovascularization (drug therapy, etiology)
  • Drug Therapy, Combination
  • Humans
  • Macular Degeneration (complications)
  • Photochemotherapy (methods)
  • Photosensitizing Agents (therapeutic use)
  • Porphyrins (therapeutic use)
  • Randomized Controlled Trials as Topic
  • Vascular Endothelial Growth Factor A (antagonists & inhibitors)
  • Verteporfin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: